PRMT7 Antibody (YA1734)
(Synonyms: SBIDDS)Based on 1 Customer Validation
PRMT7 Antibody (YA1734) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PRMT7.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
|---|---|
| Dilution Ratio | 1:500-1:1000 |
Product Details
PRMT7 Antibody (YA1734) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PRMT7.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 78 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 78 kDa
Entrez Gene: 54496 Human ; 214572 Mouse ; 361402 Rat
SwissProt: Q9NVM4 Human ; Q922X9 Mouse ; Q5U4E8 Rat
OMIM: 617157 Human
A synthetic peptide of human PRMT7
Endogenous
Affinity Purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Verification Images
-
Western blot analysis was performed on extracts from HepG2 (lane 1, 15 μg), Hela (lane 2, 15 μg), 293 (lane 3, 15 μg), MCF-7 (lane 4, 15 μg), 3T3 (lane 5, 15 μg), and Jurkat (lane 6, 15 μg) using PRMT7 Rabbit mAb.Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST at 4°C overnight.The primary antibody (1:1000 dilution) and the loading control antibody (GAPDH, HY-P80137, 1:90000 dilution) were incubated in 5% non-fat milk in TBST for 1 hour at 37°C.Goat Anti-Rabbit IgG-HRP Secondary Antibody (1:20000 dilution) was then applied for 40 minutes at 37°C.
-
Western blot analysis of extracts from K562(lane 2(20ug) , NIH/3T3(lane 3(20ug) and Hela(lane 4(20ug) using PRMT7 Antibody (HY-P81989) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P83730, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Background
-
Function
PRMT7 is a unique member of the protein arginine methyltransferase (PRMT) family that catalyzes the ω-monomethylation of arginine residues in a substrate-specific manner[1][2][3]. Mechanistically, PRMT7 preferentially targets arginine residues within R-X-R motifs flanked by basic amino acids and exhibits optimal enzymatic activity at lower-than-physiological temperatures, distinguishing it from other PRMT isoforms[1][4]. PRMT7-mediated arginine methylation regulates chromatin structure, RNA splicing, stress response, and cell stemness, thereby influencing gene expression, muscle stem cell physiology, B cell immunity, and neural development[2][3][5][6]. In disease models, PRMT7 deficiency in mice causes defects in muscle satellite cells and immune cell function, while humans with PRMT7 mutations display intellectual disability, hypotonia, and facial dysmorphisms, highlighting its developmental relevance[2][3]. Compared with PRMT5 and PRMT9, PRMT7 exclusively produces monomethylarginine, lacks significant symmetric or asymmetric dimethylation, and shows distinct substrate recognition, particularly for histone H2B and R-X-R motifs[1][4][7]. For experimental applications, selective PRMT7 inhibitors have been developed, enabling modulation of its methyltransferase activity in cellular assays and cancer models, with co-inhibition of PRMT4/5/7 demonstrating synergistic suppression of tumor cell growth[2][6][8]. Collectively, PRMT7 functions as a context-dependent regulator of arginine methylation with implications for epigenetic regulation, RNA processing, and disease modeling[1][2][3][4][6].
-
Subcellular Localization
Cytoplasm, cytosol; Nucleus
-
Isoforms & Post-Translational Modification
Q9NVM4 has 4 isomers: Q9NVM4-1: 78459 Da (predicted); Q9NVM4-2: 62118 Da (predicted); Q9NVM4-3: 73154 Da (predicted); Q9NVM4-4: 63806 Da (predicted).
-
Subunit
Homodimer and heterodimer (By similarity). Interacts with CTCFL (By similarity). Interacts with PRMT5 and SNRPD3
-
SwissProt ID
-
Synonyms
SBIDDS
-
Research Field
Epigenetics and Nuclear Signaling
Documentation
-
Data Sheet (262 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)
[1]. Miranda TB, et al. PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity. J Biol Chem. 2004 May 28;279(22):22902-7. [Content Brief]
[2]. Jain K, et al. PRMT7 as a unique member of the protein arginine methyltransferase family: A review. Arch Biochem Biophys. 2019 Apr 15;665:36-45. [Content Brief]
[3]. Hsieh HC, et al. PRMT-7/PRMT7 activates HLH-30/TFEB to guard plasma membrane integrity compromised by bacterial pore-forming toxins. Autophagy. 2024 Jun;20(6):1335-1358. [Content Brief]
[4]. Zurita-Lopez CI, et al. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues. J Biol Chem. 2012 Mar 9;287(11):7859-70. [Content Brief]
[5]. Wang CD, et al. Developmental expression of three prmt genes in Xenopus. Zool Res. 2019 Mar 18;40(2):102-107. [Content Brief]
[6]. Li WJ, et al. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth. Nat Commun. 2021 Mar 29;12(1):1946. [Content Brief]
[7]. Rabezanahary H, et al. Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada. Heliyon. 2024 May 21;10(10):e31026. [Content Brief]
[8]. Feoli A, et al. Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor. J Med Chem. 2023 Oct 12;66(19):13665-13683. [Content Brief]